Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

84 structures for P28072

Entry ID Method Resolution Chain Position Source
4R3O X-ray 260 A H/V 35-236 PDB
4R67 X-ray 289 A H/V/j/x 35-236 PDB
5A0Q EM 350 A H/V 35-239 PDB
5GJQ EM 450 A a/o 1-239 PDB
5GJR EM 350 A a/o 1-239 PDB
5L4G EM 402 A 6/Z 1-239 PDB
5LE5 X-ray 180 A N/b 35-239 PDB
5LEX X-ray 220 A N/b 35-239 PDB
5LEY X-ray 190 A N/b 35-239 PDB
5LEZ X-ray 219 A N/b 35-239 PDB
5LF0 X-ray 241 A N/b 35-239 PDB
5LF1 X-ray 200 A N/b 35-239 PDB
5LF3 X-ray 210 A N/b 36-239 PDB
5LF4 X-ray 199 A N/b 35-239 PDB
5LF6 X-ray 207 A N/b 35-239 PDB
5LF7 X-ray 200 A N/b 35-239 PDB
5LN3 EM 680 A 1 1-239 PDB
5M32 EM 380 A N/b 1-239 PDB
5T0C EM 380 A AN/BN 2-239 PDB
5T0G EM 440 A N 2-239 PDB
5T0H EM 680 A N 2-239 PDB
5T0I EM 800 A N 2-239 PDB
5T0J EM 800 A N 2-239 PDB
5VFO EM 350 A N/n 35-225 PDB
5VFP EM 420 A N/n 35-225 PDB
5VFQ EM 420 A N/n 35-225 PDB
5VFR EM 490 A N/n 35-225 PDB
5VFS EM 360 A N/n 35-225 PDB
5VFT EM 700 A N/n 35-225 PDB
5VFU EM 580 A N/n 35-225 PDB
6KWY EM 272 A N/b 1-239 PDB
6MSB EM 300 A N/n 2-239 PDB
6MSD EM 320 A N/n 2-239 PDB
6MSE EM 330 A N/n 2-239 PDB
6MSG EM 350 A N/n 2-239 PDB
6MSH EM 360 A N/n 2-239 PDB
6MSJ EM 330 A N/n 2-239 PDB
6MSK EM 320 A N/n 2-239 PDB
6R70 EM 350 A N/b 35-237 PDB
6REY EM 300 A H/V 35-239 PDB
6RGQ EM 260 A H/V 35-239 PDB
6WJD EM 480 A N/n 2-239 PDB
6WJN EM 570 A N/n 35-225 PDB
6XMJ EM 300 A H 35-236 PDB
7LXV EM 340 A N/b 35-239 PDB
7NAN EM 280 A N/b 1-239 PDB
7NAO EM 290 A N/b 1-239 PDB
7NAP EM 320 A N/b 1-239 PDB
7NAQ EM 320 A N/b 1-239 PDB
7NHT EM 280 A N 1-239 PDB
7PG9 EM 370 A H/V 35-239 PDB
7QXN EM 370 A N/n 2-239 PDB
7QXP EM 360 A N/n 2-239 PDB
7QXU EM 430 A N/n 2-239 PDB
7QXW EM 410 A N/n 2-239 PDB
7QXX EM 440 A N/n 2-239 PDB
7QY7 EM 470 A N/n 2-239 PDB
7QYA EM 480 A N/n 2-239 PDB
7QYB EM 410 A N/n 2-239 PDB
7V5G EM 447 A A/H 35-239 PDB
7V5M EM 388 A H/V 35-239 PDB
7W37 EM 300 A N/n 1-239 PDB
7W38 EM 310 A N/n 1-239 PDB
7W39 EM 320 A N/n 1-239 PDB
7W3A EM 350 A N/n 1-239 PDB
7W3B EM 360 A N/n 1-239 PDB
7W3C EM 340 A N/n 1-239 PDB
7W3F EM 330 A N/n 1-239 PDB
7W3G EM 320 A N/n 1-239 PDB
7W3H EM 320 A N/n 1-239 PDB
7W3I EM 350 A N/n 1-239 PDB
7W3J EM 350 A N/n 1-239 PDB
7W3K EM 360 A N/n 1-239 PDB
7W3M EM 350 A N/n 1-239 PDB
8BZL X-ray 214 A N/b 1-239 PDB
8CVR EM 270 A H/V 35-239 PDB
8CVS EM 310 A N/b 35-239 PDB
8CVT EM 300 A N/n 1-239 PDB
8CXB EM 290 A N/b 1-239 PDB
8QYN EM 288 A Q 1-239 PDB
8QYO EM 284 A N/b 1-239 PDB
8QYS EM 389 A Q/h 35-231 PDB
8UD9 EM 204 A H/V 35-239 PDB
AF-P28072-F1 Predicted AlphaFoldDB

182 variants for P28072

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1204392723
CA397281821
2 A>T No ClinGen
gnomAD
rs749731543
CA8310819
3 A>P No ClinGen
ExAC
gnomAD
rs771111047
CA8310820
4 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs771111047
CA397281861
4 T>P No ClinGen
ExAC
TOPMed
gnomAD
CA8310821
rs200484344
5 L>S No ClinGen
1000Genomes
ExAC
gnomAD
rs1435860259
CA397281975
8 A>S No ClinGen
gnomAD
CA397282009
rs1168577648
8 A>V No ClinGen
gnomAD
CA8310825
rs761713056
9 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs371587768
CA8310824
9 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA397282059
rs980249539
10 G>E No ClinGen
TOPMed
gnomAD
CA287177311
rs980249539
10 G>V No ClinGen
TOPMed
gnomAD
CA287177326
rs140751461
11 A>D No ClinGen
1000Genomes
gnomAD
rs1366407685
CA397282073
11 A>P No ClinGen
gnomAD
CA397282065
rs1366407685
11 A>T No ClinGen
gnomAD
CA8310826
rs764908804
12 G>R No ClinGen
ExAC
gnomAD
rs1272469828
CA397282146
13 P>L No ClinGen
gnomAD
TCGA novel 13 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1227552805
CA397282135
13 P>S No ClinGen
gnomAD
TCGA novel 14 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397282191
rs1256483754
15 P>Q No ClinGen
TOPMed
rs750440943
CA8310827
15 P>S No ClinGen
ExAC
gnomAD
CA397282239
rs1223360638
16 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1217513442
CA397282294
17 W>C No ClinGen
TOPMed
CA8310829
rs766281129
17 W>L No ClinGen
ExAC
gnomAD
CA397282261
rs1252466180
17 W>R No ClinGen
TOPMed
gnomAD
rs751075026
CA8310830
18 G>R No ClinGen
ExAC
CA8310833
rs752324933
19 P>L No ClinGen
ExAC
gnomAD
CA397282367
rs780845009
19 P>S No ClinGen
ExAC
gnomAD
CA8310832
rs780845009
19 P>T No ClinGen
ExAC
gnomAD
CA8310835
rs778000428
20 E>K No ClinGen
ExAC
gnomAD
CA397282410
rs1417923958
20 E>V No ClinGen
gnomAD
rs938713750
CA287177371
21 A>V No ClinGen
TOPMed
rs1567516862
CA397282550
23 T>I No ClinGen
Ensembl
rs1327566969
CA397282595
24 P>R No ClinGen
gnomAD
rs1433999842
CA397282626
25 D>E No ClinGen
gnomAD
rs1371451553
CA397282598
25 D>Y No ClinGen
gnomAD
CA8310839
rs745965445
29 R>* No ClinGen
ExAC
rs772252014
CA8310840
30 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA8310841
rs775892066
31 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA397282916
rs1273782199
32 S>F No ClinGen
TOPMed
gnomAD
rs780266728
CA8310860
36 T>A No ClinGen
ExAC
gnomAD
rs1213363628
CA397283267
37 I>T No ClinGen
TOPMed
CA8310861
rs747052551
38 M>V No ClinGen
ExAC
gnomAD
CA8310862
rs768763951
39 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA397283364
rs1567517041
40 V>L No ClinGen
Ensembl
rs928708017
CA287177717
41 Q>R No ClinGen
TOPMed
CA8310866
rs143768117
44 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8310865
rs143768117
44 G>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8310870
rs760167981
50 A>T No ClinGen
ExAC
gnomAD
rs753501942
CA8310872
53 R>T No ClinGen
ExAC
gnomAD
CA397284623
rs1269569061
56 T>A No ClinGen
TOPMed
rs1455471170 57 G>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA287178449
rs141042303
58 S>Y No ClinGen
ESP
TOPMed
gnomAD
CA397284951
rs1460423458
61 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA397284970
rs1263627997
62 N>H No ClinGen
gnomAD
CA8310902
rs182638722
62 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs748430072
CA8310903
63 R>* No ClinGen
ExAC
gnomAD
CA397284993
rs748430072
63 R>G No ClinGen
ExAC
gnomAD
rs1443496514
CA397285110
68 L>V No ClinGen
gnomAD
rs771829144
CA8310907
70 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA397285145
rs1326320092
70 P>S No ClinGen
gnomAD
rs1339549445
COSM980687
CA397285213
73 D>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA8310910
rs768105769
74 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA8310911
rs776218041
74 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1485634812
CA397285294
77 C>F No ClinGen
TOPMed
CA397285351
rs1260813123
78 C>* No ClinGen
gnomAD
CA8310914
rs772949966
82 S>L No ClinGen
ExAC
gnomAD
CA397285476
rs1206996001
83 A>P No ClinGen
TOPMed
rs1001789495
CA287178603
84 A>T No ClinGen
TOPMed
CA287178605
rs1057338477
85 D>E No ClinGen
TOPMed
rs763461081
CA8310915
87 Q>H No ClinGen
ExAC
gnomAD
CA397285645
rs1392498926
89 V>A No ClinGen
gnomAD
CA397285729
COSM178974
rs1294459124
92 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1381006278
CA397285735
93 V>I No ClinGen
gnomAD
rs766735155
CA8310916
95 Y>H No ClinGen
ExAC
gnomAD
CA397285903
rs371370042
98 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs371370042
CA8310919
98 G>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1567517386
CA397285923
98 G>V No ClinGen
Ensembl
rs1354753654
CA397285935
99 F>I No ClinGen
TOPMed
CA397285989
rs1336438585
100 H>Q No ClinGen
TOPMed
gnomAD
TCGA novel 101 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1161682393
CA397286199
104 L>V No ClinGen
TOPMed
gnomAD
rs59124255
CA287178829
106 E>D No ClinGen
Ensembl
rs2304974
CA8310941
VAR_020030
107 P>A No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs2304974
CA8310942
107 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8310943
rs368699351
108 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA397286285
rs1312425998
110 V>I No ClinGen
TOPMed
gnomAD
rs1448052163
CA397286348
113 A>P No ClinGen
gnomAD
rs781327581
CA8310946
113 A>V No ClinGen
ExAC
gnomAD
rs1392817087
CA397286406
114 A>G No ClinGen
gnomAD
CA397286441
rs2304975
115 S>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8310948
rs769496105
115 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs149312249
CA287178907
122 Y>* No ClinGen
ESP
TOPMed
CA397286662
rs1460527381
123 R>* No ClinGen
TOPMed
CA8310950
rs144706895
123 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs200783412
CA287178950
125 R>Q No ClinGen
TOPMed
CA8310952
rs773838062
129 M>I No ClinGen
ExAC
gnomAD
CA397286898
rs1250859844
130 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA397286970
rs1191482242
133 I>T No ClinGen
TOPMed
rs1450869965
CA397287025
135 A>T No ClinGen
TOPMed
rs1273612090
CA397287042
135 A>V No ClinGen
TOPMed
CA397287073
rs1239155948
137 W>S No ClinGen
gnomAD
rs1454058158
CA397287089
138 D>N No ClinGen
gnomAD
CA8310956
rs761154471
139 P>L No ClinGen
ExAC
gnomAD
rs764525435
CA8310957
140 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs761758329
CA8310959
142 G>A No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel
CA8310958
rs776695359
142 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ExAC
gnomAD
TCGA novel 144 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1597310878
CA397287386
145 V>G No ClinGen
Ensembl
rs755934836
CA8310983
145 V>M No ClinGen
ExAC
gnomAD
rs756836433
CA8310986
148 V>L No ClinGen
ExAC
gnomAD
rs1044855414
CA287179174
150 M>I No ClinGen
TOPMed
gnomAD
COSM436794
CA8310987
rs778268975
150 M>V Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 152 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397287516
rs1567517575
153 M>V No ClinGen
Ensembl
rs1240803023 153 M>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA397287565
rs1193701659
155 V>I No ClinGen
TOPMed
gnomAD
CA8310988
rs148466899
159 F>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1474008466
CA397287678
160 A>G No ClinGen
gnomAD
rs758048137
CA8310989
161 I>V No ClinGen
ExAC
gnomAD
CA8310991
rs747395317
162 G>A No ClinGen
ExAC
gnomAD
CA397287798
rs1400581334
166 S>N No ClinGen
gnomAD
rs1298866065
CA397287825
167 S>F No ClinGen
gnomAD
rs1354969847
CA397287855
169 I>V No ClinGen
TOPMed
gnomAD
rs769974567
CA8310995
173 V>G No ClinGen
ExAC
gnomAD
rs1235608302
CA397287967
174 D>H No ClinGen
TOPMed
CA8310997
rs763062365
176 T>A No ClinGen
ExAC
gnomAD
CA397288033
rs1223525417
177 Y>S No ClinGen
gnomAD
CA8311001
rs760599519
178 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA8311000
rs760599519
178 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs774669346
CA8310999
178 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs753866752
CA8311002
179 E>Q No ClinGen
ExAC
CA397288085
rs1256177779
180 G>V No ClinGen
gnomAD
rs1189023671
CA397288099
181 M>K No ClinGen
gnomAD
rs761666299
CA8311003
181 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs761666299
CA397288092
181 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA8311005
rs749930693
183 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA287179289
rs113625242
187 L>P No ClinGen
Ensembl
rs199961729
CA8311008
189 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8311009
rs755401852
191 A>V No ClinGen
ExAC
gnomAD
CA8311010
rs376453032
192 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1567517644
CA397288309
193 A>T No ClinGen
Ensembl
CA8311026
rs751271152
195 A>D No ClinGen
ExAC
TOPMed
gnomAD
CA397288697
rs553921552
195 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs553921552
CA8311025
195 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA397288772
rs1567517685
197 A>V No ClinGen
Ensembl
rs1462851615
CA397288805
198 M>T No ClinGen
TOPMed
rs1403060312
CA397288799
198 M>V No ClinGen
gnomAD
CA397288835
rs1392168790
199 E>A No ClinGen
TOPMed
rs150542791
CA8311029
200 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs767131809
CA8311028
200 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1567517698
CA397288868
201 D>N No ClinGen
Ensembl
CA8311031
rs547244513
208 I>S No ClinGen
1000Genomes
ExAC
gnomAD
CA397289115
rs547244513
208 I>T No ClinGen
1000Genomes
ExAC
gnomAD
CA287179408
rs952750072
209 R>C No ClinGen
gnomAD
rs952750072
CA397289126
209 R>G No ClinGen
gnomAD
rs1236134203
CA397289134
209 R>H No ClinGen
TOPMed
gnomAD
CA8311033
rs757483744
212 A>T No ClinGen
ExAC
gnomAD
rs1420941869
CA397289216
213 I>S No ClinGen
TOPMed
CA397289253
rs1259530338
215 E>D No ClinGen
gnomAD
CA397289243
rs1193582566
215 E>K No ClinGen
gnomAD
rs908573412
CA287179422
219 E>G No ClinGen
Ensembl
CA397289325
rs755217976
220 R>L No ClinGen
ExAC
TOPMed
gnomAD
COSM178976
rs755217976
CA8311034
220 R>Q large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA397289342
rs1250949301
222 V>I No ClinGen
gnomAD
rs1199565466
CA397289366
225 G>E No ClinGen
gnomAD
CA8311035
rs745872929
225 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
CA8311036
rs772211985
226 D>N No ClinGen
ExAC
rs775729803
CA8311037
228 I>T No ClinGen
ExAC
rs917481855
CA287179437
228 I>V No ClinGen
Ensembl
CA397289403
rs1253283971
229 P>L No ClinGen
TOPMed
CA8311038
rs747940154
230 K>N No ClinGen
ExAC
TCGA novel 232 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs143389701
CA8311040
232 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8311042
rs201170982
233 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8311043
rs201170982
233 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs374601335
CA8311044
234 A>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs575136248
CA8311045
235 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8311046
rs752361110
238 P>R No ClinGen
ExAC
gnomAD
CA8311048
rs148379239
239 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1804248
CA287179522
240 A>L No ClinGen
TOPMed
rs1804248
CA397289538
240 A>S No ClinGen
TOPMed

No associated diseases with P28072

1 regional properties for P28072

Type Name Position InterPro Accession
conserved_site Proteasome beta-type subunit, conserved site 38 - 85 IPR016050

Functions

Description
EC Number 3.4.25.1 Threonine endopeptidases
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Translocated from the cytoplasm into the nucleus following interaction with AKIRIN2, which bridges the proteasome with the nuclear import receptor IPO9
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
proteasome complex A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core.
proteasome core complex A multisubunit barrel shaped endoprotease complex, which is the core of the proteasome complex.
proteasome core complex, beta-subunit complex The proteasome core subcomplex that constitutes the two inner rings of the proteasome core complex. An example of this component is found in Mus musculus.

3 GO annotations of molecular function

Name Definition
cadherin binding Binding to cadherin, a type I membrane protein involved in cell adhesion.
endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
threonine-type endopeptidase activity Catalysis of the hydrolysis of internal peptide bonds in a polypeptide chain by a mechanism in which the hydroxyl group of a threonine residue at the active center acts as a nucleophile.

2 GO annotations of biological process

Name Definition
proteasomal protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.
proteasome-mediated ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3MHN0 PSMB6 Proteasome subunit beta type-6 Bos taurus (Bovine) PR
P28070 PSMB4 Proteasome subunit beta type-4 Homo sapiens (Human) PR
10 20 30 40 50 60
MAATLLAARG AGPAPAWGPE AFTPDWESRE VSTGTTIMAV QFDGGVVLGA DSRTTTGSYI
70 80 90 100 110 120
ANRVTDKLTP IHDRIFCCRS GSAADTQAVA DAVTYQLGFH SIELNEPPLV HTAASLFKEM
130 140 150 160 170 180
CYRYREDLMA GIIIAGWDPQ EGGQVYSVPM GGMMVRQSFA IGGSGSSYIY GYVDATYREG
190 200 210 220 230
MTKEECLQFT ANALALAMER DGSSGGVIRL AAIAESGVER QVLLGDQIPK FAVATLPPA